Forecasting the Global Drug Delivery Devices Market Growth at 7.90% CAGR till 2028, DelveInsight Report | Pfizer, Inc, Johnson & Johnson Services, Inc, F. Hoffmann-La Roche, Ltd, Novartis AG, 3M Bayer AG, uniQure N.V., Shenzhen (SiBiono) GeneTech Co.

As per DelveInsight's assessment, the Drug Delivery Devices Market is expected to grow at an immense pace in the coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where Drug Delivery Devices have been used, which is expected to drive the demand for Drug Delivery Devices in the upcoming years.

DelveInsight's "Drug Delivery Devices Market" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Drug Delivery Devices companies actively working in the market.

Drug Delivery Devices Overview
https://www.delveinsight.com/sample-request/drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Drug delivery devices are specialized instruments used to administer a medicinal substance or medicine through a particular route. These gadgets are a component of one or more medical interventions.

Drug Delivery Devices Market Insights
The market for drug delivery devices is expected to grow overall between 2023 and 2028 due to factors such as the rising incidence of diabetes, cancer, and other diseases, as well as technological advancements in the field of drug delivery devices and the growing geriatric population, which increases the risk of developing chronic illnesses.
DelveInsight Analysis: The Global Drug Delivery Devices market size is anticipated to reach ~USD 162 billion by 2028 with a growing CAGR of 7.90% during the forecasted period (2023-2028).

To know more about why North America is leading the market growth in the Drug Delivery Devices market, get a snapshot of the report Drug Delivery Devices Market Trends
https://www.delveinsight.com/report-store/drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Drug Delivery Devices Market Report
• On December 08, 2020, AireHealth had earned the Food and Drug Administration 510(k) clearance for portable nebulizers.
• On April 13, 2020, B Braun had received the Food and Drug Emergency Use Authorization for using infusion pumps with nebulizers for treatment of COVID-19 patients.
• On September 10, 2020, Food and Drug Administration had approved GSK's three-drug asthma inhaler.
• On April 08, 2020, FDA had approved the first generic albuterol inhaler.
• On October 15, 2019, U.S. FDA had approved the Transdermal System, the first and only transdermal patch

To read more about the latest highlights related to Drug Delivery Devices, get a snapshot of the key highlights entailed in the Drug Delivery Devices Market Forecast Report
https://www.delveinsight.com/sample-request/drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Key Players in the Drug Delivery Devices Market
Some of the key market players operating in the Drug Delivery Devices market include- Pfizer, Inc, Johnson & Johnson Services, Inc, F. Hoffmann-La Roche, Ltd, Novartis AG, 3M Bayer AG, uniQure N.V., Shenzhen (SiBiono) GeneTech Co. Ltd (Hubei Tongji Benda Ebei Pharmaceuticals), Antares Pharma, Inc, GlaxoSmithKline plc, AstraZeneca PLC, Becton Dickinson, Boehringer Ingelheim group, Consort Medical plc (Recipharm Group), Insulet Corporation, Medtronic Plc, Sulzer Ltd., West Pharmaceuticals Services, Inc, Generx Biotechnology, Panacea Pharmaceuticals Inc., Aptar Pharma, Koninklijke Philips N.V., Nemera, Biocorp Production., and Eli Lilly and Co. and others.

COVID-19 Impact Analysis on the Drug Delivery Devices Market
According to estimates, the market for medication delivery devices is dominated by North America. The importance of important growth factors like the prevalence of chronic illnesses throughout the region, the rise in research and development as a result of these conditions, the rising use of biologics, the rise in the use of medication delivery systems in home-care settings, the growing number of drug delivery device approvals in the North American region, and the government's increased emphasis on facilitating access to healthcare services have all contributed to the growth of this market.
Additionally, The drug delivery devices market has been affected positively after the emergence of the COVID-19 infections. Despite the unanticipated and catastrophic effects of the COVID-19 pandemic, the demand for drug delivery devices was positively impacted by the pandemic due to an increase in immunization rates and a rise in COVID-19 cases as a result of the pandemic's second wave. The demand for drug delivery devices, which are used to administer vaccination medications, has increased further due to the rapidly rising number of COVID-19 cases and the mounting pressure on the government to increase the number of vaccinations in order to get the population inoculated against COVID-19. So, during the projected period, the market for Drug Delivery Devices is anticipated to continue expanding (2023-2028).

Scope of the Drug Delivery Devices Market Report
• Coverage: Global
• Study Period: 2020-2028
• Drug Delivery Devices Market Segmentation By Type: Monoclonal Antibodies, Immunomodulators, Cancer Vaccines, Checkpoint Inhibitors, And Others
• Drug Delivery Devices Market Segmentation By Indication: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, And Others
• Drug Delivery Devices Market Segmentation By End User: Hospitals And Clinics, Specialty Centers, And Others
• Drug Delivery Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Drug Delivery Devices Companies: Pfizer, Inc, Johnson & Johnson Services, Inc, F. Hoffmann-La Roche, Ltd, Novartis AG, 3M Bayer AG, uniQure N.V., Shenzhen (SiBiono) GeneTech Co. Ltd (Hubei Tongji Benda Ebei Pharmaceuticals), Antares Pharma, Inc, GlaxoSmithKline plc, AstraZeneca PLC, Becton Dickinson, Boehringer Ingelheim group, Consort Medical plc (Recipharm Group), Insulet Corporation, Medtronic Plc, Sulzer Ltd., West Pharmaceuticals Services, Inc, Generx Biotechnology, Panacea Pharmaceuticals Inc., Aptar Pharma, Koninklijke Philips N.V., Nemera, Biocorp Production., and Eli Lilly and Co. and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the Drug Delivery Devices market are set to emerge as the trendsetter explore @ Drug Delivery Devices Manufacturer
https://www.delveinsight.com/sample-request/drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Drug Delivery Devices Market Report Introduction
2 Drug Delivery Devices Market Executive summary
3 Regulatory and Patent Analysis
4 Drug Delivery Devices Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Drug Delivery Devices Market
7 Drug Delivery Devices Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Drug Delivery Devices Market Drivers
11. Drug Delivery Devices Market Barriers
12. Project Approach
13. About DelveInsight

Interested in knowing how the Drug Delivery Devices market will grow by 2028? Click to get a snapshot of the Drug Delivery Devices Market Analysis
https://www.delveinsight.com/sample-request/drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Latest Reports Offered By DelveInsight:

Oncology Drugs Market
https://www.delveinsight.com/report-store/oncology-drugs-market
Oncology Drugs Market By Therapy Type (Chemotherapy, Hormonal Therapy, Targeted Therapy [Gene Therapy And Immunotherapy], And Others), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Blood Cancers, And Others), By End User (Hospitals, Specialty Clinics, And Others), and by geography is estimated to grow at a healthy CAGR forecast till 2028 due to rising prevalence of various cancers such as lung and breast cancers and growing demand for targeted therapies for cancer treatment.

Biologics Market
https://www.delveinsight.com/report-store/biologics-market
Biologics Market By Product Type (Cell-Based Biologics, Gene-Based Biologics, Monoclonal Antibodies, Vaccines, Recombinant Protiens, And Others), By Application (Oncology, Immunology, Infectious Diseases, Neurological Diseases, And Others), By Manufacturing Type (In-House And Outsourced), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to rising prevalence of autoimmune disorders such as rheumatoid arthiritis and genetic disorders.

Biosimilar Market
https://www.delveinsight.com/report-store/biosimilars-market
Biosimilars Market By Product Class (Monoclonal Antibodies, Recombinant Hormone/Proteins, Anti-Inflammatory Agents, Immunomodulators, And Others), By Manufacturing Type (In-House And Outsourced/Contract), By Application (Autoimmune Diseases, Blood Disorders, Oncology, Infectious Diseases, And Others), by geography, is projected to expand at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders such as autoimmune disorders, cancers, among others and increasing demand for biosimilar drugs owing to their cost-effectiveness.

Cancer Immunotherapy Market
https://www.delveinsight.com/report-store/cancer-immunotherapy-market
Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines, Checkpoint Inhibitors, And Others), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, And Others), By End-User (Hospitals And Clinics, Specialty Centers, And Others), and by geography is expected to rise at a significant CAGR forecast till 2027 owing to the accelerating prevalence of cancers and surging healthcare expenditure across the globe

Companion Diagnostics Market
https://www.delveinsight.com/report-store/companion-diagnostics-market
Companion Diagnostics Market By Type (Product [Assays, Kits & Reagents And Instruments], and Services), Technology (Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Others), Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, and Others), End-User (Hospitals, Diagnostic Labs, and Others), and Geography is expected to grow at a noteworthy CAGR till 2028 owing to the increase in the cancer burden across the globe and the growing focus on personalized medicines.

Contact Us
Gaurav Bora
info@delveinsight.com
+1(919)321-6187
https://www.delveinsight.com/medical-devices

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.